Innforgen Biologicals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Innforgen Biologicals Private Limited

Innforgen Biologicals Private Limited, a struck off private limited company, was established on 05 December 2018 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290TG2018PTC128774. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Arul Prakash Ramakrishnan (Director), Mohammad Abdul Azeez (Director), Muthukumar Amirthalingam (Director). It is based at Plot No. 8-2-277/46, Road No. 3 Banjara Hills,, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290TG2018PTC128774

  • Registration Number

    128774

  • Incorporation Date

    05 December 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 2 Months
Company report

Innforgen Biologicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Innforgen Biologicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Innforgen Biologicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Arul Prakash Ramakrishnan Director 05 Dec 2018 Current
Mohammad Abdul Azeez Director 05 Dec 2018 Current
Muthukumar Amirthalingam Director 05 Dec 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Innforgen Biologicals.

Enhance accessibility to Innforgen Biologicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Innforgen Biologicals revenue growth over time
Innforgen Biologicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Innforgen Biologicals?

Unlock access to Innforgen Biologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Innforgen Biologicals?

Unlock and access historical data on people associated with Innforgen Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Innforgen Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innforgen Biologicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Innforgen Biologicals
Recent Activity within the Organization
  • Director Appointment

    Arul Prakash Ramakrishnan was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Mohammad Abdul Azeez was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was completed.

  • Director Appointment

    The activity Muthukumar Amirthalingam was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was completed.

  • Company Incorporation

    Innforgen Biologicals Private Limited was registered on 05 Dec 2018 with Roc Hyderabad & aged 7 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Innforgen Biologicals Private Limited?

The CIN of Innforgen Biologicals Private Limited is U24290TG2018PTC128774.

Where is Innforgen Biologicals Private Limited headquartered?

Innforgen Biologicals Private Limited is headquartered at Plot No. 8-2-277/46, Road No. 3 Banjara Hills,, Hyderabad, Telangana, 500034.

When was Innforgen Biologicals Private Limited incorporated?

Innforgen Biologicals Private Limited was incorporated on 05 December 2018.

Who are the current directors of Innforgen Biologicals Private Limited?

The current directors of Innforgen Biologicals Private Limited are

What is the primary industry of Innforgen Biologicals Private Limited?

The primary industry of Innforgen Biologicals Private Limited is Pharma.

Is Innforgen Biologicals Private Limited a listed company?

Innforgen Biologicals Private Limited is unlisted.

What is the capital structure of Innforgen Biologicals Private Limited?

The authorized capital of Innforgen Biologicals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available